BioCentury
ARTICLE | Financial News

Neurocrine off on indiplon news

June 16, 2006 11:18 PM UTC

NBIX fell $4.19 (22%) to $15.18 on 11.9 million shares on Friday after disclosing late Thursday the contents of an approvable letter and a not approvable letter it received in May for two formulations...